
Glass Medical AI is a tech-bio company spun out of the University of Amsterdam, focused on accelerating cancer therapy development through predictive AI technology. Their mission is to enable smarter, more precise clinical trials by helping pharma and biotech partners stratify patients and design studies more effectively. The company's technology supports rapid patient stratification and trial design across various cancer indications, aiming to bring breakthrough therapies to patients faster and improve outcomes. They combine AI expertise with deep medical knowledge to reduce development risk and deliver the right treatments to the right patients. Their business model appears to be B2B services leveraging their AI platform for drug development companies.

Glass Medical AI is a tech-bio company spun out of the University of Amsterdam, focused on accelerating cancer therapy development through predictive AI technology. Their mission is to enable smarter, more precise clinical trials by helping pharma and biotech partners stratify patients and design studies more effectively. The company's technology supports rapid patient stratification and trial design across various cancer indications, aiming to bring breakthrough therapies to patients faster and improve outcomes. They combine AI expertise with deep medical knowledge to reduce development risk and deliver the right treatments to the right patients. Their business model appears to be B2B services leveraging their AI platform for drug development companies.